alphaveHCG₹703.50

Healthcare Global Enterprises Ltd.

Annual Quarterly₹ CrorePeersAPOLLOHOSP FORTIS RAINBOW JLHL CORONA MARKSANS METROPOLIS PARKHOSPSMcap ₹10,123 Cr

View

In ₹ Crore except Per Share 12 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	486.9	469.9	494.6	525.6	553.5	557.6	585.2	613.2	646.9	633.1	652.3	695.1
Other Income	3.4	6.1	5.1	8.8	11.1	5.7	10.2	6.8	2.6	2.5	13.1	12.1
Total Income	490.3	475.9	499.7	534.4	564.7	563.2	595.4	620.0	649.5	635.5	665.4	707.2
Expenses
+ Purchases of Stock-in-Trade	122.1	112.6	124.7	135.7	148.6	151.8	154.1	166.3	181.2	173.4	180.7	186.8
+ Changes in Inventories	-1.2	1.3	-1.9	-2.5	-4.4	-2.7	-0.1	-4.5	-4.1	3.1	-4.0	-8.0
+ Employee Benefit Expense	77.2	77.3	76.9	85.2	85.3	90.2	92.8	97.8	94.2	94.2	92.5	104.5
+ Finance Costs	26.9	29.5	26.8	33.7	36.0	40.7	44.2	45.5	43.6	44.8	42.7	39.9
+ Depreciation & Amortisation	43.2	44.2	46.0	47.0	49.7	56.5	58.1	57.9	62.8	60.7	62.8	70.4
+ Other Expenses	204.3	200.0	203.0	216.3	221.8	230.8	232.6	245.7	252.2	252.7	258.1	289.5
Total Expenses	472.4	464.9	475.4	515.4	537.0	567.4	581.7	608.8	630.0	628.9	632.8	683.1
EBITDA	84.6	78.6	92.0	90.9	102.3	87.4	105.7	107.8	123.3	109.6	125.1	122.3
EBIT	41.4	34.5	46.1	43.9	52.5	30.8	47.7	49.9	60.5	49.0	62.3	51.8
Profit
PBT before Exceptional Items	17.9	11.1	24.3	19.0	27.7	-4.2	13.7	11.2	19.5	6.7	32.6	24.1
+ Exceptional Items	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	-12.7	-31.9	0.0
Pretax Income	17.9	11.1	28.2	19.0	27.7	-4.2	13.7	11.2	19.5	-6.0	0.7	24.1
+ Current Tax	8.5	8.7	7.6	7.7	11.1	-2.6	12.6	8.9	8.1	4.4	-1.6	8.7
+ Deferred Tax	-1.4	-1.1	-2.8	-2.3	-4.1	-8.4	-5.7	-3.0	-8.9	-2.6	-1.2	-0.1
Tax Expense	7.1	7.6	4.8	5.4	7.0	-11.1	6.9	5.9	-0.8	1.8	-2.8	8.6
+ Share of Associates & JVs	-0.0	-0.0	0.1	-0.0	-0.0	0.9	-0.1	0.7	0.3	-0.1	0.5	0.9
Net Income	10.8	3.4	23.5	13.6	20.7	7.8	6.8	6.0	20.7	-7.9	4.0	16.5
+ Net Income — Continuing Ops	10.8	3.4	23.4	13.6	20.7	6.9	6.9	5.3	20.4	-7.9	3.5	15.5
+ Other Comprehensive Income	-1.4	-1.3	3.7	0.6	0.4	0.6	0.2	0.3	0.6	2.1	1.7	0.5
Total Comprehensive Income	9.4	2.2	27.1	14.3	21.0	8.3	7.0	6.2	21.2	-5.8	5.7	17.0
Net Income to Common	13.6	5.7	21.3	12.1	18.0	7.0	7.4	4.8	16.3	-9.4	2.2	13.8
Minority Interest	-2.8	-2.3	2.2	1.6	2.7	0.8	-0.6	1.2	4.4	1.5	1.9	2.7
Per Share
Basic EPS	0.98	0.41	1.53	0.87	1.29	0.50	0.53	0.34	1.16	-0.68	0.15	0.92
Diluted EPS	0.97	0.41	1.51	0.86	1.28	0.49	0.52	0.34	1.16	-0.68	0.15	0.92
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	0.2	0.3	0.6	2.1	1.7	0.5
+ Items NOT to be Reclassified to P&L	0.0	0.0	-0.7	0.0	0.0	-0.1	0.2	0.0	0.1	0.6	0.1	0.0
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	0.0	0.0	0.1	0.0	0.0	0.0
+ Items to be Reclassified to P&L	-1.4	-1.3	4.3	0.6	0.4	0.7	0.0	0.3	0.5	1.5	1.5	0.5
Comprehensive Income — Owners of Parent	-1.3	-1.2	24.7	12.5	0.4	0.6	7.6	4.9	0.8	1.5	2.1	0.5
Comprehensive Income — Non-controlling Interests	-0.1	-0.1	2.4	1.8	-0.0	-0.0	-0.6	1.3	-0.2	0.6	-0.4	0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	0.98	0.41	1.53	0.87	1.29	0.50	0.53	0.34	1.16	-0.68	0.15	0.92
Diluted EPS — Continuing Operations	0.97	0.41	1.51	0.86	1.28	0.49	0.52	0.34	1.16	-0.68	0.15	0.92
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	366.1	356.0	371.9	392.4	409.3	408.4	431.1	451.3	469.7	456.5	475.6	516.3
Gross Margin %	75.18	75.75	75.19	74.65	73.94	73.26	73.68	73.60	72.61	72.11	72.91	74.28
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	17.9	11.1	24.3	19.0	27.7	-4.2	13.7	11.2	19.5	6.7	32.6	24.1
− Exceptional Items (reconciliation)	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	-12.7	-31.9	0.0
Net Income Adj (tax-effected)	10.8	3.4	20.2	13.6	20.7	7.8	6.8	6.0	20.7	4.8	36.0	16.5
EPS Adj	0.98	0.41	1.32	0.87	1.29	0.50	0.53	0.34	1.16	0.41	1.33	0.92
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	139.3	139.3	139.3	139.4	139.4	139.4	139.4	139.4	141.0	141.0	149.3	149.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.